Cargando…

SARS‐CoV‐2 research using human pluripotent stem cells and organoids

Experimental cell models are indispensable for clarifying the pathophysiology of coronavirus disease 2019 (COVID‐19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, and for developing therapeutic agents. To recapitulate the symptoms and drug response of CO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deguchi, Sayaka, Serrano‐Aroca, Ángel, Tambuwala, Murtaza M., Uhal, Bruce D., Brufsky, Adam M., Takayama, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Concise Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550698/ https://www.ncbi.nlm.nih.gov/pubmed/34302450 http://dx.doi.org/10.1002/sctm.21-0183

Ejemplares similares

Would New SARS-CoV-2 Variants Change the War against COVID-19?
por: Redwan, Elrashdy M., et al.
Publicado: (2022)

Clinical utility of novel biosensing platform: Diagnosis of coronavirus SARS-CoV-2 at point of care
por: Aljabali, Alaa A.A., et al.
Publicado: (2021)

Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features
por: Hassan, Sk. Sarif, et al.
Publicado: (2020)

Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2021)

Implications derived from S-protein variants of SARS-CoV-2 from six continents
por: Hassan, Sk. Sarif, et al.
Publicado: (2021)

Toward Precision Medicine with Human Pluripotent Stem Cells for Diabetes
por: Memon, Bushra, et al.
Publicado: (2022)

Using Pluripotent Stem Cells to Understand Normal and Leukemic Hematopoietic Development
por: Bigas, Anna, et al.
Publicado: (2022)

Co-infection associated with SARS-CoV-2 and their management
por: Chavda, Vivek P, et al.
Publicado: (2023)

The potential of induced pluripotent stem cells for discriminating neurodevelopmental disorders
por: Stock, Ricarda, et al.
Publicado: (2020)

Modeling aortic diseases using induced pluripotent stem cells
por: Zhu, Kai, et al.
Publicado: (2020)

Frontiers in Antimicrobial Materials
por: Serrano-Aroca, Ángel, et al.
Publicado: (2022)

Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives
por: Demirci, Selami, et al.
Publicado: (2020)

Biocompatible Films of Calcium Alginate Inactivate Enveloped Viruses Such as SARS-CoV-2
por: Cano-Vicent, Alba, et al.
Publicado: (2022)

Pluripotent Stem Cells in Clinical Setting—New Developments and Overview of Current Status
por: Ilic, Dusko, et al.
Publicado: (2022)

Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution
por: Hassan, Sk Sarif, et al.
Publicado: (2022)

Systems for the Functional Evaluation of Human Heart Tissues Derived from Pluripotent Stem Cells
por: Murata, Kozue, et al.
Publicado: (2022)

Non-uniform aspects of the SARS-CoV-2 intraspecies evolution reopen question of its origin
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

The importance of accessory protein variants in the pathogenicity of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

Hematopoietic stem cell‐ and induced pluripotent stem cell‐derived CAR‐NK cells as reliable cell‐based therapy solutions
por: Arias, Jonathan, et al.
Publicado: (2021)

Inherited cardiac diseases, pluripotent stem cells, and genome editing combined—the past, present, and future
por: van den Brink, Lettine, et al.
Publicado: (2019)

Neuronal cell‐based medicines from pluripotent stem cells: Development, production, and preclinical assessment
por: Sun, Yun, et al.
Publicado: (2021)

Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells
por: Wang, Li‐Tzu, et al.
Publicado: (2021)

The Importance of Research on the Origin of SARS-CoV-2
por: Lundstrom, Kenneth, et al.
Publicado: (2020)

Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases
por: Maepa, Setjie W., et al.
Publicado: (2020)

A human induced pluripotent stem cell‐based modular platform to challenge sensorineural hearing loss
por: Zine, Azel, et al.
Publicado: (2021)

Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine
por: Poetsch, Mareike S, et al.
Publicado: (2022)

Questions concerning the proximal origin of SARS‐CoV‐2
por: Seyran, Murat, et al.
Publicado: (2020)

A unique view of SARS-CoV-2 through the lens of ORF8 protein
por: Hassan, Sk Sarif, et al.
Publicado: (2021)

Design of a chimeric ACE-2/Fc-silent fusion protein with ultrahigh affinity and neutralizing capacity for SARS-CoV-2 variants
por: Bodie, Neil M, et al.
Publicado: (2023)

Regulatory considerations for developing a phase I investigational new drug application for autologous induced pluripotent stem cells‐based therapy product
por: Jha, Balendu Shekhar, et al.
Publicado: (2020)

Atopic dermatitis is not associated with SARS-CoV-2 outcomes
por: Rakita, Uros, et al.
Publicado: (2021)

Estimating the predictive value of negative severe acute respiratory coronavirus virus 2 (SARS-CoV-2) results: A prospective study
por: Hirschwerk, David, et al.
Publicado: (2020)

Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area
por: Lewis, Sarah S., et al.
Publicado: (2020)

An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

Establishment of SLC15A1/PEPT1-Knockout Human-Induced Pluripotent Stem Cell Line for Intestinal Drug Absorption Studies
por: Kawai, Kanae, et al.
Publicado: (2019)

Antimicrobial Face Shield: Next Generation of Facial Protective Equipment against SARS-CoV-2 and Multidrug-Resistant Bacteria
por: Tuñón-Molina, Alberto, et al.
Publicado: (2021)

Evaluation of appropriate transmission-based precautions for non-SARS-CoV-2 respiratory viruses
por: Falk, Cassandra L., et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust
por: Grant, Joseph J., et al.
Publicado: (2020)

Sensitivity of midturbinate versus nasopharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Jamal, Alainna J., et al.
Publicado: (2020)

Alginate: Enhancement Strategies for Advanced Applications
por: Hurtado, Alejandro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q7t8jb3i170qga3fv6d5lejcer